About this trial
The aim of this project is to create a registry of diabetic patients, containing a detailed clinical profile of each patient, along with omics data, which will be analyzed using artificial intelligence algorithms, and their results will be implemented in the form of new recommendations of care for high-risk patients and those already suffering from diabetes.
The study will be conducted prospectively. The project participants will be patients with diabetes, patients at high risk of developing diabetes and a control group of normoglycemic patients who will participate in study visits at the Clinical Research Center of the Medical University of Bialystok.
Eligibility criteria
Qualifiers
patients with diagnosed diabetes (according to the American Diabetes Association criteria) - diabetes group
patients with diagnosed prediabetes (IFG and/or IGT) - prediabetes group
patients with normoglycemia (NFG and NGT) - normoglycemia group
informed consent
Disqualifiers
drug addiction
severe psychiatric disorders
patients with gestational diabetes mellitus
patients unable to give informed consent, legally incompetent or incapable to comply with the study terms and conditions
Trial design
Treatments tested in this trial
- Observational study - registry